5-{(dimethylcarbamoyl)oxy)-3-((2-(2-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)ethoxy)ethyl)carbamoyl}-1-methyl-quinolin-1-ium triflate

ID: ALA4168520

Chembl Id: CHEMBL4168520

PubChem CID: 145952779

Max Phase: Preclinical

Molecular Formula: C29H31F3N4O10S

Molecular Weight: 535.58

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)C(=O)Oc1cccc2c1cc(C(=O)NCCOCCOCCN1C(=O)c3ccccc3C1=O)c[n+]2C.O=S(=O)([O-])C(F)(F)F

Standard InChI:  InChI=1S/C28H30N4O7.CHF3O3S/c1-30(2)28(36)39-24-10-6-9-23-22(24)17-19(18-31(23)3)25(33)29-11-13-37-15-16-38-14-12-32-26(34)20-7-4-5-8-21(20)27(32)35;2-1(3,4)8(5,6)7/h4-10,17-18H,11-16H2,1-3H3;(H,5,6,7)

Standard InChI Key:  LFGCRRHRHMMUPN-UHFFFAOYSA-N

Associated Targets(Human)

ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
APP Tclin Amyloid-beta A4 protein (8510 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ACHE Acetylcholinesterase (1035 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 535.58Molecular Weight (Monoisotopic): 535.2187AlogP: 1.78#Rotatable Bonds: 11
Polar Surface Area: 118.36Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.91CX Basic pKa: CX LogP: -2.72CX LogD: -2.72
Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.23Np Likeness Score: -0.79

References

1. Ţînţaş ML, Gembus V, Alix F, Barré A, Coadou G, Truong L, Sebban M, Papamicaël C, Oulyadi H, Levacher V..  (2018)  Rational design of carbamate-based dual binding site and central AChE inhibitors by a "biooxidisable" prodrug approach: Synthesis, in vitro evaluation and docking studies.,  155  [PMID:29886321] [10.1016/j.ejmech.2018.05.057]

Source